11 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

maiLink

FDA 510(k)
FDA Class 2 ·Radiology

iSmile

FDA UDI
Ismile Dental Products, Inc.·00816419021600·Headrest Cover Tissue/Poly 13" x 10" Lavender

LOQTEQ®

FDA UDI
aap Implantate AG·04042409403514·LOQTEQ® VA Cortical Screw 2.5, T8, L 8 Titanium

INVISION Total Ankle Revision System

FDA 510(k)
FDA Class 2 ·Orthopedic

E-Z-EM ENDOSCOPIC CO2 REGULATOR

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

ENDOPATH ILS ENDOSCOPIC CURVED INTRALUMINAL STAPLER - 29 MM

FDA Adverse Event
Injury ·ETHICON ENDO-SURGERY, LLC·Product code OCW·December 3, 2008

ACCESS 2 IMMUNOASSAY SYSTEM

FDA Adverse Event
Malfunction ·BECKMAN COULTER, INC.·Product code JJE·September 9, 2011

PENUMBRA NON-STERILE PUMP MAX CANISTER

FDA Adverse Event
Malfunction ·PENUMBRA, INC.·Product code JCX·July 29, 2013

Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.

FDA Enforcement
Class II ·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014

Alcon Custom Ophthalmic Surgical Procedure Packs

FDA Enforcement
Class II ·Terminated·Alcon Research, LLC·April 7, 2021